20131-39-9 Usage
Description
1-(4-amino-phenyl)-2-morpholin-4-yl-ethanol is a chemical compound belonging to the phenyl morpholine class, characterized by the presence of a morpholine ring, a benzene ring with an amino group, and an ethanol group. This versatile structure, with its diverse functional groups, makes it a valuable intermediate in the synthesis of pharmaceuticals and other organic compounds, particularly for medicinal chemistry applications.
Uses
Used in Pharmaceutical Synthesis:
1-(4-amino-phenyl)-2-morpholin-4-yl-ethanol is used as an intermediate in the pharmaceutical industry for the synthesis of various drugs and biologically active molecules. Its unique structure and functional groups allow for a wide range of chemical reactions, making it a promising candidate for the development of new medications.
Used in Biochemical Research:
In the field of biochemical research, 1-(4-amino-phenyl)-2-morpholin-4-yl-ethanol is used as a potential glycosidase inhibitor due to its morpholine moiety. This application makes it a valuable tool for studying enzyme inhibition and the development of therapies targeting glycosidase-related diseases.
Used in Chemical Reactions:
1-(4-amino-phenyl)-2-morpholin-4-yl-ethanol is also used as a versatile reactant in various chemical reactions across different industries, taking advantage of its multiple functional groups to produce a range of organic compounds for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 20131-39-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,1,3 and 1 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 20131-39:
(7*2)+(6*0)+(5*1)+(4*3)+(3*1)+(2*3)+(1*9)=49
49 % 10 = 9
So 20131-39-9 is a valid CAS Registry Number.
20131-39-9Relevant articles and documents
THIA-TETRAAZAACENAPHTHYLENE KINASE INHIBITORS
-
, (2008/06/13)
The present invention is directed to novel thia-tetraazaacenaphthylene compounds of Formula (I): and pharmaceutically acceptable forms thereof and their synthesis and use as inhibitors of ATP-protein kinase interactions.
